Table 5 Showing sub-group analysis of HCV prevalence by sample size, year of publication, and sub-regions of African countries
| Â | Prevalence of HCV | 95% confidence interval | Heterogeneity (I2%) | P-value |
|---|---|---|---|---|
Sub-group analysis by sample size | ||||
1. < 101 | 14.28 | 1.16–27.40 | 94.8 | P = 0.001 |
2. 101–384 | 1.19 | 0.54–1.84 | 21.8 | P = 0.269 |
3. 385–1000 | 7.04 | 2.46–11.62 | 97.6 | P < 0.001 |
4. > 1000 | 1.26 | 0.67–1.85 | - | - |
Sub-group analysis by year of publication | ||||
1. < 2011 | 3.74 | 2.24–5.23 | 94.2 | P < 0.001 |
2. 2011–2021 | 17.94 | 17.94–24.75 | 95.7 | P < 0.001 |
Sub-group analysis by regions of Africa | ||||
1. North Africa | 11.23 | 5.76–17.02 | 97.8 | P < 0.001 |
2. East Africa | 1.32 | 0.17–2.48 | - | - |
3. Middle Africa | 1.69 | 0.004–3.33 | - | - |
4. Western Africa | 3.04 | 1.08–4.99 | 65.5 | P < 0.033 |
5. South Africa | 2.90 | 1.04–4.78 | - | - |